Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company’s equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Reported DateTime | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | Filing |
2024-02-20 4:49 pm Sale | 13D | KALVISTA PHARMACEUTICALS INC C KALV | TCG Crossover GP I LLC | 2,700,840 6.52% | -707,241 (-20.75%) | View |
2024-02-13 4:27 pm Sale | 13G | CYMABAY THERAPEUTICS INC CBAY | TCG Crossover GP I LLC | 0 0% | -5,905,400 (Position Closed) | View |
2024-02-09 4:31 pm Purchase | 13G | CG ONCOLOGY INC CGON | TCG Crossover GP I LLC | 3,570,206 5.4% | 3,570,206 (New Position) | View |
2024-02-09 4:29 pm Purchase | 13G | AN2 THERAPEUTICS INC ANTX | TCG Crossover GP I LLC | 2,678,209 9% | 1,388,889 (+107.72%) | View |
2024-02-09 4:28 pm Purchase | 13G | AEROVATE THERAPEUTICS INC AVTE | TCG Crossover GP I LLC | 2,201,274 8% | 2,201,274 (New Position) | View |
2024-02-09 4:24 pm Sale | 13G | TAYSHA GENE THERAPIES INC TSHA | TCG Crossover GP I LLC | 2,912,861 1.6% | -8,198,250 (-73.78%) | View |
2024-02-09 4:22 pm Purchase | 13G | TOURMALINE BIO INC TRML | TCG Crossover GP I LLC | 1,477,593 5.9% | 1,477,593 (New Position) | View |
2024-02-09 4:22 pm Purchase | 13G | COGENT BIOSCIENCES INC COGT | TCG Crossover GP I LLC | 5,631,042 6.5% | 2,000,000 (+55.08%) | View |
2023-08-28 4:08 pm Purchase | 13G | COMPASS PATHWAYS PLC SPONSORED CMPS | TCG Crossover GP I LLC | 6,437,497 9.9% | 6,437,497 (New Position) | View |
2023-08-25 4:22 pm Purchase | 13G | TAYSHA GENE THERAPIES INC TSHA | TCG Crossover GP I LLC | 11,111,111 5.9% | 11,111,111 (New Position) | View |
2023-07-25 4:19 pm Purchase | 13G | AN2 THERAPEUTICS INC ANTX | TCG Crossover GP I LLC | 1,289,320 6.6% | 1,289,320 (New Position) | View |
2023-07-25 4:18 pm Purchase | 13G | ICOSAVAX INC ICVX | TCG Crossover GP I LLC | 3,703,704 7.5% | 3,703,704 (New Position) | View |
2023-07-25 4:17 pm Purchase | 13G | SAVARA INC SVRA | TCG Crossover GP I LLC | 10,000,000 7.4% | 10,000,000 (New Position) | View |
2023-02-14 2:23 pm Purchase | 13G | COGENT BIOSCIENCES INC COGT | TCG Crossover GP I LLC | 3,631,042 5.2% | 3,631,042 (New Position) | View |
2023-02-14 2:23 pm Purchase | 13G | CYMABAY THERAPEUTICS INC CBAY | TCG Crossover GP I LLC | 5,905,400 6.2% | 5,905,400 (New Position) | View |
2023-02-14 2:23 pm Purchase | 13G | SILENCE THERAPEUTICS PLC SPONS SLN | TCG Crossover GP I LLC | 6,314,625 5.9% | 6,314,625 (New Position) | View |
2023-02-14 2:23 pm Purchase | 13G | VIRIDIAN THERAPEUTICS INC VRDN | TCG Crossover GP I LLC | 983,610 2.4% | 983,610 (New Position) | View |
2023-01-09 4:19 pm Purchase | 13D | KALVISTA PHARMACEUTICALS INC C KALV | TCG Crossover GP I LLC | 3,408,081 9.9% | 3,408,081 (New Position) | View |